https://cardiacbiotech.com/cardiac-biotech-solutions-activates-china-production-pipeline-for-mycardia-at-and-moves-into-final-nmpa-submission-phase/ https://cardiacbiotech.com/cardiac-biotech-solutions-inc-secures-health-canada-license-for-mycardia-at-device-now-branded-as-cardioholter-at/ https://cardiacbiotech.com/cbsc-announces-375000-purchase-order-and-launch-of-recurring-revenue-program-with-noventis-medical/ https://cardiacbiotech.com/cardiac-biotech-solutions-inc-cbsc-signs-exclusive-5-year-distribution-agreement-with-noventis-medical-covering-costa-rica-panama-colombia-and-argentina/ https://cardiacbiotech.com/cb-scientific-inc-cbsc-announces-corporate-name-change-to-cardiac-biotech-solutions-inc/